Statins: are they appropriate for all patients?
- PMID: 35180403
- PMCID: PMC8846614
- DOI: 10.1016/S2214-109X(21)00572-6
Statins: are they appropriate for all patients?
Conflict of interest statement
FJR has received research grants, honoraria, or consulting fees for advisory board membership or professional input from Amgen, Regeneron, Sanofi, and Novartis, and delivered lectures for these companies. FM declares no competing interests.
Comment on
-
Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.Lancet Glob Health. 2022 Mar;10(3):e369-e379. doi: 10.1016/S2214-109X(21)00551-9. Lancet Glob Health. 2022. PMID: 35180420 Free PMC article.
References
-
- Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472. - PMC - PubMed
-
- Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis from 90 056 participants in 14 randomised trials with statins. Lancet. 2005;366:1267–1278. - PubMed
-
- Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388:2532–2561. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical